Search research articles
Contact Us
Filters
Showing results (311-320 of 441) with videos related to
Page
of 45
Sort By:
Journal of Hepatology
|
November 28, 2012
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
Graham R Foster, Stefan Zeuzem, Pietro Andreone, et al.
Journal of Cannabis Research
|
June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Tangui Barré, Fabrice Carrat, Clémence Ramier, et al.
Journal of Hepatology
|
August 20, 2014
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis
David Saadoun, Matthieu Resche Rigon, Stanislas Pol, et al.
Journal of Hepatology
|
August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death
Mathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
Plos One
|
March 21, 2014
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection
Simone Bocchetta, Patrick Maillard, Mami Yamamoto, et al.
Journal of Hepatology
|
September 2, 2017
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder
Vincent Mallet, Julie Bruneau, Julien Zuber, et al.
Journal of Viral Hepatitis
|
May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort
Victor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2014
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Thomas Berg, Pietro Andreone, Stanislas Pol, et al.
Nature Immunology
|
February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clémence Hollande, Jeremy Boussier, James Ziai, et al.
Annals of the Rheumatic Diseases
|
November 15, 2015
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
David Saadoun, Vincent Thibault, Si Nafa Si Ahmed, et al.
Page
of 45
Search research articles
Search
Showing results (311-320 of 441) with videos related to
Sort By:
Page
of 45
Journal of Hepatology
|
November 28, 2012
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
Graham R Foster, Stefan Zeuzem, Pietro Andreone, et al.
Journal of Cannabis Research
|
June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Tangui Barré, Fabrice Carrat, Clémence Ramier, et al.
Journal of Hepatology
|
August 20, 2014
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis
David Saadoun, Matthieu Resche Rigon, Stanislas Pol, et al.
Journal of Hepatology
|
August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death
Mathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
Plos One
|
March 21, 2014
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection
Simone Bocchetta, Patrick Maillard, Mami Yamamoto, et al.
Journal of Hepatology
|
September 2, 2017
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder
Vincent Mallet, Julie Bruneau, Julien Zuber, et al.
Journal of Viral Hepatitis
|
May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort
Victor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2014
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Thomas Berg, Pietro Andreone, Stanislas Pol, et al.
Nature Immunology
|
February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clémence Hollande, Jeremy Boussier, James Ziai, et al.
Annals of the Rheumatic Diseases
|
November 15, 2015
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
David Saadoun, Vincent Thibault, Si Nafa Si Ahmed, et al.
Page
of 45